Ipsen Bioscience Inc.
Records under this name other than patents Ipsen Bioscience Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Ipsen Bioscience Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,637,531 | Selective Cartilage Therapy Formerly held In force · High confidence | In force | High confidence | |
| US 11,071,726 | Treating Gastric Cancer Using Combination Therapies Comprising Liposomal Irinotecan, Oxaliplatin, 5-Fluorouracil (and Leucovorin) Formerly held Lapsed on the fee record Ended Jul 27, 2025 · High confidence | Lapsed on the fee record | Ended Jul 27, 2025 | High confidence |